Halogen Bonding at the Active Sites of Human Cathepsin L and MEK1 Kinase: Efficient Interactions in Different Environments

In two series of small‐molecule ligands, one inhibiting human cathepsin L (hcatL) and the other MEK1 kinase, biological affinities were found to strongly increase when an aryl ring of the inhibitors is substituted with the larger halogens Cl, Br, and I, but to decrease upon F substitution. X‐ray co‐crystal structure analyses revealed that the higher halides engage in halogen bonding (XB) with a backbone CO in the S3 pocket of hcatL and in a back pocket of MEK1. While the S3 pocket is located at the surface of the enzyme, which provides a polar environment, the back pocket in MEK1 is deeply buried in the protein and is of pronounced apolar character. This study analyzes environmental effects on XB in protein–ligand complexes. It is hypothesized that energetic gains by XB are predominantly not due to water replacements but originate from direct interactions between the XB donor (CarylX) and the XB acceptor (CO) in the correct geometry. New X‐ray co‐crystal structures in the same crystal form (space group P212121) were obtained for aryl chloride, bromide, and iodide ligands bound to hcatL. These high‐resolution structures reveal that the backbone CO group of Gly61 in most hcatL co‐crystal structures maintains water solvation while engaging in XB. An arylCF3‐substituted ligand of hcatL with an unexpectedly high affinity was found to adopt the same binding geometry as the aryl halides, with the CF3 group pointing to the CO group of Gly61 in the S3 pocket. In this case, a repulsive F2CF⋅⋅⋅OC contact apparently is energetically overcompensated by other favorable protein–ligand contacts established by the CF3 group.

[1]  M. Chudziński,et al.  Anion receptors composed of hydrogen- and halogen-bond donor groups: modulating selectivity with combinations of distinct noncovalent interactions. , 2011, Journal of the American Chemical Society.

[2]  Pierangelo Metrangolo,et al.  Halogen bonding in halocarbon-protein complexes: a structural survey. , 2011, Chemical Society reviews.

[3]  C. Lukacs,et al.  Design and synthesis of novel allosteric MEK inhibitor CH4987655 as an orally available anticancer agent. , 2011, Bioorganic & medicinal chemistry letters.

[4]  Chao Xu,et al.  Structural basis for the recognition and cleavage of histone H3 by cathepsin L , 2011, Nature communications.

[5]  D. Banner,et al.  Systematische Untersuchung von Halogenbrücken in Protein‐Ligand‐ Wechselwirkungen , 2011 .

[6]  A. Vulpetti,et al.  Fluorine–Protein Interactions and 19F NMR Isotropic Chemical Shifts: An Empirical Correlation with Implications for Drug Design , 2011, ChemMedChem.

[7]  François Diederich,et al.  Systematic investigation of halogen bonding in protein-ligand interactions. , 2011, Angewandte Chemie.

[8]  Timothy Clark,et al.  Halogen bonding: an electrostatically-driven highly directional noncovalent interaction. , 2010, Physical chemistry chemical physics : PCCP.

[9]  Mohammed G. Sarwar,et al.  Thermodynamics of halogen bonding in solution: substituent, structural, and solvent effects. , 2010, Journal of the American Chemical Society.

[10]  Molekulare Erkennung in der aktiven Tasche der Catechol-O- Methyltransferase: energetisch günstige Verdrängung eines von einem Bisubstratinhibitor importierten Wassermoleküls† , 2009 .

[11]  Edilio Borroni,et al.  Molecular recognition at the active site of catechol-o-methyltransferase: energetically favorable replacement of a water molecule imported by a bisubstrate inhibitor. , 2009, Angewandte Chemie.

[12]  S. Rick,et al.  Free energies and entropies of water molecules at the inhibitor-protein interface of DNA gyrase. , 2009, Journal of the American Chemical Society.

[13]  Weiliang Zhu,et al.  Halogen bonding--a novel interaction for rational drug design? , 2009, Journal of medicinal chemistry.

[14]  C. Hunter,et al.  Non-covalent interactions between iodo-perfluorocarbons and hydrogen bond acceptors. , 2009, Chemical communications.

[15]  Pavel Hobza,et al.  Br···O Complexes as Probes of Factors Affecting Halogen Bonding: Interactions of Bromobenzenes and Bromopyrimidines with Acetone. , 2009, Journal of chemical theory and computation.

[16]  S. Kazmirski,et al.  Beyond the MEK-pocket: can current MEK kinase inhibitors be utilized to synthesize novel type III NCKIs? Does the MEK-pocket exist in kinases other than MEK? , 2009, Bioorganic & medicinal chemistry letters.

[17]  P. Metrangolo,et al.  Halogen Versus Hydrogen , 2008, Science.

[18]  Pierangelo Metrangolo,et al.  Halogenbrücken in der supramolekularen Chemie , 2008 .

[19]  Pierangelo Metrangolo,et al.  Halogen bonding in supramolecular chemistry. , 2008, Angewandte Chemie.

[20]  Pavel Hobza,et al.  Investigations into the Nature of Halogen Bonding Including Symmetry Adapted Perturbation Theory Analyses. , 2008, Journal of chemical theory and computation.

[21]  Daniel F Ortwine,et al.  4-anilino-5-carboxamido-2-pyridone derivatives as noncompetitive inhibitors of mitogen-activated protein kinase kinase. , 2007, Journal of medicinal chemistry.

[22]  Kevin E. Riley,et al.  Insights into the strength and origin of halogen bonding: the halobenzene-formaldehyde dimer. , 2007, The journal of physical chemistry. A.

[23]  Timothy Clark,et al.  Halogen bonding: the σ-hole , 2007 .

[24]  Peter Politzer,et al.  An overview of halogen bonding , 2007, Journal of molecular modeling.

[25]  Amir Karton,et al.  Co-Crystallization of Sym-Triiodo-Trifluorobenzene with Bipyridyl Donors: Consistent Formation of Two Instead of Anticipated Three N···I Halogen Bonds , 2007 .

[26]  Peter Politzer,et al.  σ‐Hole bonding and hydrogen bonding: Competitive interactions , 2007 .

[27]  J. Lauher,et al.  Preparation of Poly(diiododiacetylene), an Ordered Conjugated Polymer of Carbon and Iodine , 2006, Science.

[28]  M. Gütschow,et al.  Interaction of papain-like cysteine proteases with dipeptide-derived nitriles. , 2005, Journal of medicinal chemistry.

[29]  Pierangelo Metrangolo,et al.  Halogen bonding based recognition processes: a world parallel to hydrogen bonding. , 2005, Accounts of chemical research.

[30]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[31]  Eric Westhof,et al.  Halogen bonds in biological molecules. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Berthelot,et al.  Halogen-bond geometry: a crystallographic database investigation of dihalogen complexes. , 2003, Acta crystallographica. Section B, Structural science.

[33]  J. Rebek,et al.  Nitrogen−Halogen Intermolecular Forces in Solution , 1999 .

[34]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[35]  Frank H. Allen,et al.  The Nature and Geometry of Intermolecular Interactions between Halogens and Oxygen or Nitrogen , 1996 .

[36]  Gautam R. Desiraju,et al.  Supramolecular Synthons in Crystal Engineering—A New Organic Synthesis , 1995 .

[37]  Gautam R. Desiraju Supramolekulare Synthone für das Kristall‐Engineering ‐ eine neue organische Synthese , 1995 .

[38]  R. S. Coleman,et al.  Reversible covalent inhibition of papain by a peptide nitrile. Carbon-13 NMR evidence for a thioimidate ester adduct , 1986 .

[39]  O. Hassel,et al.  Structural aspects of interatomic charge-transfer bonding. , 1970, Science.

[40]  A. Bondi van der Waals Volumes and Radii , 1964 .

[41]  N. A. Sörensen,et al.  The Structure of Bromine 1,4-Dioxanate. , 1954 .